These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15691265)

  • 21. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.
    Sommerer C; Giese T; Meuer S; Zeier M
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1030-7. PubMed ID: 21060169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunosuppression for kidney transplant recipients: current strategies].
    Alberú J; Urrea EM
    Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy.
    Velickovic-Radovanovic RM; Paunovic G; Mikov M; Djordjevic V; Stojanovic M; Catic-Djordjevic A; Cvetkovic T
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):505-10. PubMed ID: 20102364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug regimens affect cadaveric kidney graft survival.
    Kauffman HM; Cherikh WS; Delmonico FL
    Transplant Proc; 2001; 33(1-2):1029-30. PubMed ID: 11267176
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
    Filler G; Foster J; Berard R; Mai I; Lepage N
    Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
    Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
    Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation.
    de Jonge H; Naesens M; Kuypers DR
    Ther Drug Monit; 2009 Aug; 31(4):416-35. PubMed ID: 19536049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation?
    Capron A; Haufroid V; Wallemacq P
    Pharmacol Res; 2016 Sep; 111():610-618. PubMed ID: 27468645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.
    Filler G
    Transpl Int; 2004 Mar; 17(3):120-5. PubMed ID: 14749919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of cyclosporine in renal transplantation.
    Hesselink DA; Smak Gregoor PJ; Weimar W
    Transplant Proc; 2004 Mar; 36(2 Suppl):99S-106S. PubMed ID: 15041316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point: A call for advanced pharmacokinetic and pharmacodynamic monitoring to guide calcineurin inhibitor dosing in renal transplant recipients.
    van Rossum HH; Press RR; den Hartigh J; de Fijter JW
    Clin Chem; 2010 May; 56(5):732-5. PubMed ID: 20207765
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
    Baraldo M; Isola M; Feruglio MT; Francesconi A; Franceschi L; Tursi V; Livi U; Furlanut M
    Transplant Proc; 2005 Jun; 37(5):2240-3. PubMed ID: 15964387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current status of therapeutic drug monitoring for immunosuppressive drugs].
    Uchida K
    Nihon Rinsho; 2005 Nov; 63(11):2022-9. PubMed ID: 16277269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients.
    Ghio L; Ferraresso M; Viganò SM; Ginevri F; Perfumo F; Gianoglio B; Murer L; Zacchello G; Dello Strologo L; Cardillo M; Tirelli S; Valente U; Edefonti A
    Transplant Proc; 2005 Mar; 37(2):856-8. PubMed ID: 15848555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.
    van Hest RM; Mathot RA; Pescovitz MD; Gordon R; Mamelok RD; van Gelder T
    J Am Soc Nephrol; 2006 Mar; 17(3):871-80. PubMed ID: 16452491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.